AAAAAA

   
Results: 1-25 | 26-50 | 51-74
Results: 1-25/74
Making a living out of the art of dying
Authors: Dove, A
Citation: A. Dove, Making a living out of the art of dying, NAT BIOTECH, 19(7), 2001, pp. 615-619
Big pharmas seek biotechs that deliver
Authors: Dove, A
Citation: A. Dove, Big pharmas seek biotechs that deliver, NAT BIOTECH, 19(5), 2001, pp. 398-398
Survey raises concerns about Bt resistance management
Authors: Dove, A
Citation: A. Dove, Survey raises concerns about Bt resistance management, NAT BIOTECH, 19(4), 2001, pp. 293-294
Betting on biogenerics
Authors: Dove, A
Citation: A. Dove, Betting on biogenerics, NAT BIOTECH, 19(2), 2001, pp. 117-120
The bittersweet promise of glycobiology
Authors: Dove, A
Citation: A. Dove, The bittersweet promise of glycobiology, NAT BIOTECH, 19(10), 2001, pp. 913-917
Biotech weighs up the options in obesity
Authors: Dove, A
Citation: A. Dove, Biotech weighs up the options in obesity, NAT BIOTECH, 19(1), 2001, pp. 25-28
Proteomics: Basic research climbs aboard
Authors: Dove, A
Citation: A. Dove, Proteomics: Basic research climbs aboard, NAT MED, 7(9), 2001, pp. 984-984
Stem cell researchers ponder worst-case scenario
Authors: Dove, A
Citation: A. Dove, Stem cell researchers ponder worst-case scenario, NAT MED, 7(8), 2001, pp. 876-876
Report predicts burgeoning vaccine markets
Authors: Dove, A
Citation: A. Dove, Report predicts burgeoning vaccine markets, NAT MED, 7(8), 2001, pp. 877-877
New addiction research unlikely to be applied
Authors: Dove, A
Citation: A. Dove, New addiction research unlikely to be applied, NAT MED, 7(7), 2001, pp. 757-757
FDA tightens human oversight
Authors: Dove, A
Citation: A. Dove, FDA tightens human oversight, NAT MED, 7(6), 2001, pp. 646-646
US postdocs in line for benefits
Authors: Dove, A
Citation: A. Dove, US postdocs in line for benefits, NAT MED, 7(5), 2001, pp. 519-519
Osteoporosis drugs show promise against malaria
Authors: Dove, A
Citation: A. Dove, Osteoporosis drugs show promise against malaria, NAT MED, 7(4), 2001, pp. 389-389
New reporting rules for gene therapy and xeno trials
Authors: Dove, A
Citation: A. Dove, New reporting rules for gene therapy and xeno trials, NAT MED, 7(3), 2001, pp. 265-265
Clinton gives chimps a home
Authors: Dove, A
Citation: A. Dove, Clinton gives chimps a home, NAT MED, 7(2), 2001, pp. 138-138
Patents not key barrier to AIDS therapy
Authors: Dove, A
Citation: A. Dove, Patents not key barrier to AIDS therapy, NAT MED, 7(12), 2001, pp. 1262-1262
New class of HIV drugs shows promise
Authors: Dove, A
Citation: A. Dove, New class of HIV drugs shows promise, NAT MED, 7(12), 2001, pp. 1265-1265
New rats set physiologists' hearts aflutter
Authors: Dove, A
Citation: A. Dove, New rats set physiologists' hearts aflutter, NAT MED, 7(11), 2001, pp. 1168-1168
US throws money at TSE research
Authors: Dove, A
Citation: A. Dove, US throws money at TSE research, NAT MED, 7(10), 2001, pp. 1075-1075
Is investment in bioterrorism research warranted
Authors: Dove, A
Citation: A. Dove, Is investment in bioterrorism research warranted, NAT MED, 7(1), 2001, pp. 9-9
CD18 trials disappoint again
Authors: Dove, A
Citation: A. Dove, CD18 trials disappoint again, NAT BIOTECH, 18(8), 2000, pp. 817-818
Small success for gene therapy
Authors: Dove, A
Citation: A. Dove, Small success for gene therapy, NAT BIOTECH, 18(6), 2000, pp. 592-593
Experts disagree over color of biomass
Authors: Dove, A
Citation: A. Dove, Experts disagree over color of biomass, NAT BIOTECH, 18(5), 2000, pp. 490-490
Opinions evolve on Kauffman patent
Authors: Dove, A
Citation: A. Dove, Opinions evolve on Kauffman patent, NAT BIOTECH, 18(4), 2000, pp. 373-373
Biotechnology development a stroll in the park?
Authors: Dove, A
Citation: A. Dove, Biotechnology development a stroll in the park?, NAT BIOTECH, 18(3), 2000, pp. 270-272
Risultati: 1-25 | 26-50 | 51-74